Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with.

Bone Robert R. Recker, et al. - In summary, as this trial was terminated early, there was insufficient power to compare the fracture risks between alendronate and raloxifene. Safety profiles were as expected from clinical trial and post-marketing reports Read article: http://www.mdlinx.com/OrthoLinx/xml-article.cfm/1803089.

Last Updated ( Wednesday, 28 March 2007 )